Evidence map›Paper›PMID 35078476›Full record

ArticleCancer cell international2022

Green tea-derived theabrownin induces cellular senescence and apoptosis of hepatocellular carcinoma through p53 signaling activation and bypassed JNK signaling suppression.

Jiaan Xu, Xiujuan Xiao, Bo Yan, Qiang Yuan, Xiaoqiao Dong, Quan Du, Jin Zhang, Letian Shan, Zhishan Ding, Li Zhou and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancer cell international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Jiaan XuCollege of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Xiujuan XiaoCollege of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Bo YanCollege of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Qiang YuanCollege of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Xiaoqiao DongDepartment of Neurosurgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
Quan DuDepartment of Neurosurgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
Jin ZhangTheabio Co., Ltd, Hangzhou, 310000, China.
Letian ShanThe First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, 310053, China. letian.shan@zcmu.edu.cn.ORCID http://orcid.org/0000-0003-4926-0527
Zhishan DingCollege of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, China. dzszjtcm@163.com.
Li ZhouThe First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, 310053, China. zhouli@zcmu.edu.cn.
Thomas EfferthDepartment of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Germany.
Zhejiang Chinese Medical University · CNHangzhou First People's Hospital · CNJohannes Gutenberg University Mainz · DE

Funding

National Natural Science Foundation of China 81873049National Natural Science Foundation of China 82074464Natural Science Foundation of Zhejiang Province LY18H270004Natural Science Foundation of Zhejiang Province LY18H270016
6 · The paper itself

Abstract

backgroundTheabrownin (TB) is a bioactive component of tea and has been reported to exert effects against many human cancers, but its efficacy and mechanism on hepatocellular carcinoma (HCC) with different p53 genotypes remains unclarified.

methodsMTT assay, DAPI staining, flow cytometry and SA-β-gal staining were applied to evaluate the effects of TB on HCC cells. Quantitative real time PCR (qPCR) and Western blot (WB) were conducted to explore the molecular mechanism of TB. A xenograft model of zebrafish was established to evaluate the anti-tumor effect of TB.

resultsMTT assays showed that TB significantly inhibited the proliferation of SK-Hep-1, HepG2, and Huh7 cells in a dose-dependent manner, of which SK-Hep-1 was the most sensitive one with the lowest IC

conclusionsTo sum up, TB exerted tumor-inhibitory, pro-senescent and pro-apoptotic effects on SK-Hep-1 cells through ATM-Chk2-p53 signaling axis in accompany with JNK bypass regulation. This is the first report on the pro-senescent effect and multi-target (p53 and JNK) mechanism of TB on HCC cells, providing new insights into the underlying mechanisms of TB's anti-HCC efficacy.

Indexed as

ApoptosisCellular senescenceHepatocellular carcinomaJNKp53SK-Hep-1Theabrownin

Identifiers

PMID35078476
PMCPMC8788116
OpenAlexW4207018784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.